BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee C, Mariño-enriquez A, Ou W, Zhu M, Ali RH, Chiang S, Amant F, Gilks CB, van de Rijn M, Oliva E, Debiec-rychter M, Dal Cin P, Fletcher JA, Nucci MR. The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor. American Journal of Surgical Pathology 2012;36:641-53. [DOI: 10.1097/pas.0b013e31824a7b1a] [Cited by in Crossref: 208] [Cited by in F6Publishing: 214] [Article Influence: 20.8] [Reference Citation Analysis]
Number Citing Articles
1 Hinchcliff E, Lawson B, Fleming ND. Other rare uterine sarcomas: Adenosarcoma, endometrial stromal sarcoma, STUMP. Diagnosis and Treatment of Rare Gynecologic Cancers 2023. [DOI: 10.1016/b978-0-323-82938-0.00010-0] [Reference Citation Analysis]
2 Aseervatham J. Interactions between 14-3-3 Proteins and Actin Cytoskeleton and Its Regulation by microRNAs and Long Non-Coding RNAs in Cancer. Endocrines 2022;3:665-702. [DOI: 10.3390/endocrines3040057] [Reference Citation Analysis]
3 Nucci MR, Webster F, Croce S, George S, Howitt BE, Ip PP, Lee C, Rabban JT, Soslow RA, van der Griend R, Lax SF, Mccluggage WG. Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal of Gynecological Pathology 2022;41:S44-S63. [DOI: 10.1097/pgp.0000000000000911] [Reference Citation Analysis]
4 Rahaman J, Cohen CJ. Gynecologic Sarcomas. Holland‐Frei Cancer Medicine 2022. [DOI: 10.1002/9781119000822.hfcm108.pub2] [Reference Citation Analysis]
5 R Gregg A. A rare case of high-grade endometrial stromal sarcoma initially misdiagnosed as a uterine fibroid in a postmenopausal woman. Int J Case Rep Images 2022;13:122-127. [DOI: 10.5348/101341z01ag2022cr] [Reference Citation Analysis]
6 Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group. Gynecol Oncol 2022:S0090-8258(22)00515-7. [PMID: 36114030 DOI: 10.1016/j.ygyno.2022.07.031] [Reference Citation Analysis]
7 Mahapatra M, Nayak B, Parija J, Nilavu LK, Mohapatra J, Padhy AK, Besra K. Clinicopathological Profile, Surgical Practices and Outcomes of the Patients with Uterine Sarcoma: A Single Institutional Study from Eastern India. Journal of South Asian Federation of Obstetrics and Gynaecology 2022;14:415-419. [DOI: 10.5005/jp-journals-10006-2078] [Reference Citation Analysis]
8 Bhatt A, Mishra S, Glehen O. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site—a Review. Indian J Surg Oncol 2022. [DOI: 10.1007/s13193-022-01612-9] [Reference Citation Analysis]
9 Liu J, Wang Z. Advances in the Preoperative Identification of Uterine Sarcoma. Cancers 2022;14:3517. [DOI: 10.3390/cancers14143517] [Reference Citation Analysis]
10 Agaimy A, Clarke BA, Kolin DL, Lee CH, Lee JC, McCluggage WG, Pöschke P, Stoehr R, Swanson D, Turashvili G, Beckmann MW, Hartmann A, Antonescu CR, Dickson BC. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. Am J Surg Pathol 2022. [PMID: 35575789 DOI: 10.1097/PAS.0000000000001915] [Reference Citation Analysis]
11 Gonsalves C, Ross J, Esnakula A, Leon M. Metastatic High-Grade Endometrial Stromal Sarcoma with BCOR Translocation to the Pleural Fluid: A Case Report. Int J Surg Pathol 2022;:10668969221098093. [PMID: 35570590 DOI: 10.1177/10668969221098093] [Reference Citation Analysis]
12 Dundr P, Drozenová J, Matěj R, Bártů M, Němejcová K, Robová H, Rob L, Hojný J, Stružinská I. Desmoplastic Small Round Cell Tumor of the Uterus: A Report of Molecularly Confirmed Case with EWSR1-WT1 Fusion. Diagnostics 2022;12:1184. [DOI: 10.3390/diagnostics12051184] [Reference Citation Analysis]
13 Alkanat NE, Uner A, Usubutun A. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis. Int J Surg Pathol 2022;:10668969221098087. [PMID: 35506912 DOI: 10.1177/10668969221098087] [Reference Citation Analysis]
14 Kim Y, Kim D, Sung WJ, Hong J. High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies. Front Immunol 2022;13:837004. [PMID: 35242139 DOI: 10.3389/fimmu.2022.837004] [Reference Citation Analysis]
15 Kommoss FKF, Chiang S, Köbel M, Koelsche C, Chang KT, Irving JA, Dickson B, Thiryayi S, Rouzbahman M, Rasty G, von Deimling A, Lee CH, Turashvili G. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications. Am J Surg Pathol 2022. [PMID: 35499168 DOI: 10.1097/PAS.0000000000001909] [Reference Citation Analysis]
16 Mirkovic J. Uncommon and Difficult High-Grade Endometrial Carcinomas. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.02.007] [Reference Citation Analysis]
17 Kertowidjojo EC, Bennett JA. Update on Uterine Mesenchymal Neoplasms. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.02.008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Mayr D, Horn L, Hiller GGR, Höhn AK, Schmoeckel E. Endometriale und weitere seltene uterine Sarkome. Pathologe 2022;43:183-195. [DOI: 10.1007/s00292-022-01072-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Mejbel HA, Harada S, Stevens TM, Huang X, Netto GJ, Mackinnon AC, Al Diffalha S. Spindle Cell Sarcoma of the Uterus Harboring MEIS1::NCOA1 Fusion Gene and Mimicking Endometrial Stromal Sarcoma. Int J Surg Pathol 2022;:10668969221098081. [PMID: 35477326 DOI: 10.1177/10668969221098081] [Reference Citation Analysis]
20 Crowley F, Cadoo KA, Chiang S, Mandelker DL, Bajwa R, Iasonos A, Zhou QC, Miller KM, Hensley ML, O'cearbhaill RE. Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas. Gynecologic Oncology Reports 2022;40:100980. [DOI: 10.1016/j.gore.2022.100980] [Reference Citation Analysis]
21 Bai H, Yuan F, Liang B, Sun H, Gao Y, Jin M, Xing X. Clinicopathological characteristics and treatment of patients with high-grade endometrial stromal sarcoma: A retrospective study of 40 cases. Medicine (Baltimore) 2022;101:e28490. [PMID: 35029198 DOI: 10.1097/MD.0000000000028490] [Reference Citation Analysis]
22 Yamaguchi K. Personalized Treatment in Uterine Sarcoma. Personalization in Gynecologic Oncology 2022. [DOI: 10.1007/978-981-19-4711-7_4] [Reference Citation Analysis]
23 Niu S, Zheng W. Endometrial stromal tumors: Diagnostic updates and challenges. Seminars in Diagnostic Pathology 2022. [DOI: 10.1053/j.semdp.2022.01.004] [Reference Citation Analysis]
24 Dessources K, Miller KM, Kertowidjojo E, Da Cruz Paula A, Zou Y, Selenica P, da Silva EM, Benayed R, Ashley CW, Abu-rustum NR, Dogan S, Soslow RA, Hensley ML, Weigelt B, Chiang S. ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment. Mod Pathol. [DOI: 10.1038/s41379-021-01003-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sousa FAE, Ferreira J, Cunha TM. MR Imaging of uterine sarcomas: a comprehensive review with radiologic-pathologic correlation. Abdom Radiol (NY) 2021;46:5687-706. [PMID: 34468798 DOI: 10.1007/s00261-021-03263-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Chapel DB, Nucci MR. An update in pathologic diagnosis of uterine mesenchymal tumours. Diagnostic Histopathology 2021;27:506-518. [DOI: 10.1016/j.mpdhp.2021.09.005] [Reference Citation Analysis]
27 . Pediatric Renal Tumors. Tumors of the Kidney, Bladder, and Related Urinary Structures 2021. [DOI: 10.55418/9781933477176-1] [Reference Citation Analysis]
28 Russell DH. Too Young for Clear Cell Sarcoma of the Kidney? A Case Report With Review of Differential Considerations. AJSP: Reviews and Reports 2021;26:319-325. [DOI: 10.1097/pcr.0000000000000408] [Reference Citation Analysis]
29 Tajiri T, Mima K, Kanemitsu K, Takematsu T, Kosumi K, Inoue M, Mizumoto T, Kubota T, Muto R, Murayama T, Miyanari N, Baba H. Endometrial stromal sarcoma of the sigmoid colon: a case report and literature review. Int Cancer Conf J 2021;10:294-9. [PMID: 34567941 DOI: 10.1007/s13691-021-00493-z] [Reference Citation Analysis]
30 Angione SDA, Akalu AY, Gartrell J, Fletcher EP, Burckart GJ, Reaman GH, Leong R, Stewart CF. Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted Therapy. J Pediatr Pharmacol Ther 2021;26:541-55. [PMID: 34421403 DOI: 10.5863/1551-6776-26.6.541] [Reference Citation Analysis]
31 Zerkalenkova E, Lebedeva S, Borkovskaia A, Soldatkina O, Plekhanova O, Tsaur G, Maschan M, Maschan A, Novichkova G, Olshanskaya Y. BTK, NUTM2A, and PRPF19 Are Novel KMT2A Partner Genes in Childhood Acute Leukemia. Biomedicines 2021;9:924. [PMID: 34440129 DOI: 10.3390/biomedicines9080924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Ou WB, Lundberg MZ, Zhu S, Bahri N, Kyriazoglou A, Xu L, Chen T, Mariño-Enriquez A, Fletcher JA. YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways. Oncogenesis 2021;10:37. [PMID: 33947829 DOI: 10.1038/s41389-021-00327-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Mayr D, Schmoeckel E, Höhn AK, Hiller GGR, Horn LC. [Current WHO classification of the female genitals : Many new things, but also some old]. Pathologe 2021;42:259-69. [PMID: 33822250 DOI: 10.1007/s00292-021-00933-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
34 Akaev I, Yeoh CC, Rahimi S. Update on Endometrial Stromal Tumours of the Uterus. Diagnostics (Basel) 2021;11:429. [PMID: 33802452 DOI: 10.3390/diagnostics11030429] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
35 Weisman P, Wei J, Hui P. Molecular Diagnosis. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_16] [Reference Citation Analysis]
36 Wei J, Purdy J. Uterine Mesenchymal Neoplasia. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_6] [Reference Citation Analysis]
37 Euscher ED, Buza N, Hui P. Immunohistochemistry. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_15] [Reference Citation Analysis]
38 Akiyama M, Oonishi K, Aoki K, Koshiba H. A case of low-grade endometrial stromal sarcoma diagnosed after total laparoscopic hysterectomy: A case report. JAPANESE JOURNAL OF JSGOE 2021;37:135-140. [DOI: 10.5180/jsgoe.37.1_135] [Reference Citation Analysis]
39 Adefuye P, Olawaiye A. Cancer of the Uterine Corpus. Contemporary Obstetrics and Gynecology for Developing Countries 2021. [DOI: 10.1007/978-3-030-75385-6_57] [Reference Citation Analysis]
40 Momeni-Boroujeni A, Mohammad N, Wolber R, Yip S, Köbel M, Dickson BC, Hensley ML, Leitao MM Jr, Antonescu CR, Benayed R, Ladanyi M, Lee CH, Chiang S. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma. Mod Pathol 2021;34:1008-16. [PMID: 33077922 DOI: 10.1038/s41379-020-00705-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
41 Utpatel K, Calvisi DF, Köhler G, Kühnel T, Niesel A, Verloh N, Vogelhuber M, Neu R, Hosten N, Schildhaus HU, Dietmaier W, Evert M. Complexity of PEComas : Diagnostic approach, molecular background, clinical management. Pathologe 2020;41:9-19. [PMID: 31309284 DOI: 10.1007/s00292-019-0612-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
42 Boyle W, Williams A, Sundar S, Yap J, Taniere P, Rehal P, Ganesan R. TMP3-NTRK1 rearranged uterine sarcoma: A case report. Case Rep Womens Health 2020;28:e00246. [PMID: 32939344 DOI: 10.1016/j.crwh.2020.e00246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
43 Subbaraya S, Murthy SS, Devi G S. Immunohistochemical and Molecular Characterization of Endometrial Stromal Sarcomas. Clin Pathol 2020;13:2632010X20916736. [PMID: 32524088 DOI: 10.1177/2632010X20916736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
44 Hirsch MS, Watkins J. A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls. Adv Anat Pathol 2020;27:164-92. [PMID: 31149908 DOI: 10.1097/PAP.0000000000000238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
45 Kommoss FK, Chang KT, Stichel D, Banito A, Jones DT, Heilig CE, Fröhling S, Sahm F, Stenzinger A, Hartmann W, Mechtersheimer G, Sinn HP, Schmidt D, Kommoss F, von Deimling A, Koelsche C. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications. J Pathol Clin Res 2020;6:178-84. [PMID: 32352245 DOI: 10.1002/cjp2.165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
46 Hensley ML, Chavan SS, Solit DB, Murali R, Soslow R, Chiang S, Jungbluth AA, Bandlamudi C, Srinivasan P, Tap WD, Rosenbaum E, Taylor BS, Donoghue MTA, Hyman DM. Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing. Clin Cancer Res 2020;26:3881-8. [PMID: 32299819 DOI: 10.1158/1078-0432.CCR-19-3959] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
47 Chiang S, Samore W, Zhang L, Sung YS, Turashvili G, Murali R, Soslow RA, Hensley ML, Swanson D, Dickson BC, Stewart CJR, Oliva E, Antonescu CR. PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features. Am J Surg Pathol 2019;43:810-8. [PMID: 30829727 DOI: 10.1097/PAS.0000000000001239] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
48 Cotzia P, Benayed R, Mullaney K, Oliva E, Felix A, Ferreira J, Soslow RA, Antonescu CR, Ladanyi M, Chiang S. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas. Am J Surg Pathol 2019;43:662-9. [PMID: 30789359 DOI: 10.1097/PAS.0000000000001215] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 22.5] [Reference Citation Analysis]
49 Abdrabou A, Brandwein D, Wang Z. Differential Subcellular Distribution and Translocation of Seven 14-3-3 Isoforms in Response to EGF and During the Cell Cycle. Int J Mol Sci 2020;21:E318. [PMID: 31906564 DOI: 10.3390/ijms21010318] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
50 Batra Modi K. Uterine Sarcomas: Review and Update. Recent Advances in Endometrial Cancer 2020. [DOI: 10.1007/978-981-15-5317-2_16] [Reference Citation Analysis]
51 Bhatt A, Parikh L, Mishra S, Glehen O. Approach to a Patient with Peritoneal Metastases with Unknown Primary Site: Focus on Histopathological Evaluation. Pathology of Peritoneal Metastases 2020. [DOI: 10.1007/978-981-15-3773-8_11] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Malpica A, Euscher ED, Ramalingam P, Aguilera-barrantes I, Alvarado-cabrero I. Gynecological Pathology. Oncological Surgical Pathology 2020. [DOI: 10.1007/978-3-319-96681-6_15] [Reference Citation Analysis]
53 Mishra S, Sinukumar S, Jumale N, Parikh L, Bhatt A, Glehen O. Rare Peritoneal Tumours: Histopathological Diagnosis and Patterns of Peritoneal Dissemination. Pathology of Peritoneal Metastases 2020. [DOI: 10.1007/978-981-15-3773-8_10] [Reference Citation Analysis]
54 Doval D, Pasricha S. Endometrial stromal sarcoma: A rare tumor with therapeutic conundrums. Cancer Res Stat Treat 2020;3:583. [DOI: 10.4103/crst.crst_228_20] [Reference Citation Analysis]
55 Parra-herran C. Mesenchymal and Miscellaneous Lesions of the Uterus. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00011-4] [Reference Citation Analysis]
56 Fujiishi K, Nagata S, Kano R, Kubo C, Shirayanagi M, Ozaki M, Yamamoto T, Nakanishi K, Kamiura S, Nakatsuka SI. JAZF1-SUZ12 endometrial stromal sarcoma forming subserosal masses with extraordinary uptake of fluorodeoxyglucose on positron emission tomography: a case report. Diagn Pathol 2019;14:110. [PMID: 31615558 DOI: 10.1186/s13000-019-0897-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Abdrabou A, Brandwein D, Liu C, Wang Z. Rac1 S71 Mediates the Interaction between Rac1 and 14-3-3 Proteins. Cells 2019;8:E1006. [PMID: 31480268 DOI: 10.3390/cells8091006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
58 Lax SF. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects]. Pathologe 2019;40:36-45. [PMID: 30694356 DOI: 10.1007/s00292-019-0567-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
59 Utpatel K, Calvisi DF, Köhler G, Kühnel T, Niesel A, Verloh N, Vogelhuber M, Neu R, Hosten N, Schildhaus HU, Dietmaier W, Evert M. [Complexity of PEComas : Diagnostic approach, molecular background, clinical management (German version)]. Pathologe 2019;40:443-53. [PMID: 31165234 DOI: 10.1007/s00292-019-0614-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
60 Lax SF. ♀ Mesenchymal Tumors of the Female Genital Tract. Gynecologic and Urologic Pathology 2019. [DOI: 10.1017/9781316756423.021] [Reference Citation Analysis]
61 Uddin N, Minhas K, Abdul-Ghafar J, Ahmed A, Ahmad Z. Expression of cyclin D1 in clear cell sarcoma of kidney. Is it useful in differentiating it from its histological mimics? Diagn Pathol 2019;14:13. [PMID: 30736802 DOI: 10.1186/s13000-019-0790-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
62 Zhang YY, Li Y, Qin M, Cai Y, Jin Y, Pan LY. High-grade endometrial stromal sarcoma: a retrospective study of factors influencing prognosis. Cancer Manag Res. 2019;11:831-837. [PMID: 30697075 DOI: 10.2147/cmar.s187849] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
63 Eamudomkarn N, Itarat Y, Kleebkaow P, Kietpeerakool C. A Case Report of High-Grade Endometrial Stromal Sarcoma: A Rare Cause of Abnormal Uterine Bleeding in a Young Woman. Case Rep Obstet Gynecol 2018;2018:5906760. [PMID: 30622826 DOI: 10.1155/2018/5906760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_31] [Reference Citation Analysis]
65 Wang W, Lazar AJ. Applications of Molecular Testing to Differential Diagnosis. Practical Soft Tissue Pathology: a Diagnostic Approach 2019. [DOI: 10.1016/b978-0-323-49714-5.00018-1] [Reference Citation Analysis]
66 Howitt BE, Nucci MR. Uterine Mesenchymal Lesions. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_1] [Reference Citation Analysis]
67 Fadare O, Roma AA. Mesenchymal and Miscellaneous Neoplasms of the Uterine Corpus. Atlas of Anatomic Pathology 2019. [DOI: 10.1007/978-3-030-17931-1_5] [Reference Citation Analysis]
68 Murdock TA, Veras EFT, Kurman RJ, Mazur MT. Mesenchymal Tumors and Other Rare Neoplasms. Diagnosis of Endometrial Biopsies and Curettings 2019. [DOI: 10.1007/978-3-319-98608-1_11] [Reference Citation Analysis]
69 Kyriazoglou A, Liontos M, Ziogas DC, Zagouri F, Koutsoukos K, Tsironis G, Tsiara A, Kaparelou M, Zakopoulou R, Thomakos N, Haidopoulos D, Papaspyrou I, Rodolakis A, Bamias A, Dimopoulos MA. Management of uterine sarcomas and prognostic indicators: real world data from a single-institution. BMC Cancer 2018;18:1247. [PMID: 30541504 DOI: 10.1186/s12885-018-5156-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
70 Zappacosta R, Fanfani F, Zappacosta B, Sablone F, Pansa L, Liberati M, Rosini S. Uterine Sarcomas: An Updated Overview. Neoplasm 2018. [DOI: 10.5772/intechopen.78980] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Song KJ, Yu XN, Lv T, Chen YL, Diao YC, Liu SL, Wang YK, Yao Q. Expression and prognostic value of lactate dehydrogenase-A and -D subunits in human uterine myoma and uterine sarcoma. Medicine (Baltimore) 2018;97:e0268. [PMID: 29620641 DOI: 10.1097/MD.0000000000010268] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
72 Blee AM, Liu S, Wang L, Huang H. BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion. Oncotarget 2016;7:38319-32. [PMID: 27223260 DOI: 10.18632/oncotarget.9513] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
73 Billingsley CC, Eisenhauer EL. Uterine Sarcoma. Gynecologic Care 2018. [DOI: 10.1017/9781108178594.034] [Reference Citation Analysis]
74 Verschoor AJ, Warmerdam FARM, Bosse T, Bovée JVMG, Gelderblom H. A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report. BMC Cancer 2018;18:92. [PMID: 29357824 DOI: 10.1186/s12885-018-3999-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
75 Köhler G, Zygmunt MT. Uterine Sarcomas and Atypical Smooth-Muscle Tumors: Clinic, Diagnostics and Appropriate Surgical Therapy. Hysterectomy 2018. [DOI: 10.1007/978-3-319-22497-8_14] [Reference Citation Analysis]
76 Koo SC, Perlman EJ. Molecular Pathology of Pediatric Renal Tumors. Molecular Pathology Library 2018. [DOI: 10.1007/978-3-319-89626-7_15] [Reference Citation Analysis]
77 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
78 Howitt BE, Nucci MR, Quade BJ. Uterine Mesenchymal Tumors. Diagnostic Gynecologic and Obstetric Pathology 2018. [DOI: 10.1016/b978-0-323-44732-4.00020-0] [Reference Citation Analysis]
79 Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA 3rd, Oliva E, Young RH, Hensley ML, Leitao MM Jr, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod Pathol 2018;31:674-84. [PMID: 29192652 DOI: 10.1038/modpathol.2017.162] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 19.4] [Reference Citation Analysis]
80 Busca A, Parra-Herran C. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis. Adv Anat Pathol 2017;24:354-61. [PMID: 28787279 DOI: 10.1097/PAP.0000000000000164] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
81 Brandwein D, Wang Z. Interaction between Rho GTPases and 14-3-3 Proteins. Int J Mol Sci 2017;18:E2148. [PMID: 29036929 DOI: 10.3390/ijms18102148] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
82 Lax SF. [New features in the 2014 WHO classification of uterine neoplasms]. Pathologe 2016;37:500-11. [PMID: 27738815 DOI: 10.1007/s00292-016-0230-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
83 Hoang LN, Aneja A, Conlon N, Delair DF, Middha S, Benayed R, Hensley ML, Park KJ, Hollmann TJ, Hameed MR, Antonescu CR, Soslow RA, Chiang S. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma. Am J Surg Pathol 2017;41:12-24. [PMID: 27631520 DOI: 10.1097/PAS.0000000000000721] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 16.8] [Reference Citation Analysis]
84 Vroobel KM, Karawita TS, Wilkinson N. New developments in endometrial stromal sarcoma. Diagnostic Histopathology 2017;23:311-22. [DOI: 10.1016/j.mpdhp.2017.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
85 Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA 3rd, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol 2017;30:1251-61. [PMID: 28621321 DOI: 10.1038/modpathol.2017.42] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 17.6] [Reference Citation Analysis]
86 Alessandrini L, Sopracordevole F, Bertola G, Scalone S, Urbani M, Miolo G, Perin T, Italia F, Canzonieri V. Primary extragenital endometrial stromal sarcoma of the lung: first reported case and review of literature. Diagn Pathol 2017;12:36. [PMID: 28464838 DOI: 10.1186/s13000-017-0627-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
87 Hemming ML, Wagner AJ, Nucci MR, Chiang S, Wang L, Hensley ML, George S. YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy. Gynecol Oncol 2017;145:531-5. [PMID: 28390819 DOI: 10.1016/j.ygyno.2017.03.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
88 Kerr S. Molecular Testing in Gynecologic Cancer. Diagnostic Molecular Pathology 2017. [DOI: 10.1016/b978-0-12-800886-7.00028-5] [Reference Citation Analysis]
89 Hwang H. Pathology of the Uterine Corpus. Handbook of Gynecology 2017. [DOI: 10.1007/978-3-319-17798-4_63] [Reference Citation Analysis]
90 Muñoz-zuluaga CA, Sipok A, Sardi A. Management of Peritoneal Metastasis from Uterine Sarcoma. Unusual Cases in Peritoneal Surface Malignancies 2017. [DOI: 10.1007/978-3-319-51523-6_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
91 Micci F, Gorunova L, Agostini A, Johannessen LE, Brunetti M, Davidson B, Heim S, Panagopoulos I. Cytogenetic and molecular profile of endometrial stromal sarcoma. Genes Chromosomes Cancer 2016;55:834-46. [PMID: 27219024 DOI: 10.1002/gcc.22380] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
92 Hrzenjak A. JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas. Orphanet J Rare Dis 2016;11:15. [PMID: 26879382 DOI: 10.1186/s13023-016-0400-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
93 Boyd LR. Management of Uterine Sarcomas. Current Clinical Oncology 2016. [DOI: 10.1007/7631_2016_13] [Reference Citation Analysis]
94 Lucas R, Cunha TM. Uterine Sarcomas. MRI and CT of the Female Pelvis 2016. [DOI: 10.1007/174_2016_90] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
95 Hwang H. Pathology of the Uterine Corpus. Handbook of Gynecology 2016. [DOI: 10.1007/978-3-319-17002-2_63-1] [Reference Citation Analysis]
96 Brennan MF, Antonescu CR, Alektiar KM, Maki RG. Other Uterine Sarcomas. Management of Soft Tissue Sarcoma 2016. [DOI: 10.1007/978-3-319-41906-0_21] [Reference Citation Analysis]
97 Karnezis AN, Wang Y, Ramos P, Hendricks WP, Oliva E, D'Angelo E, Prat J, Nucci MR, Nielsen TO, Chow C, Leung S, Kommoss F, Kommoss S, Silva A, Ronnett BM, Rabban JT, Bowtell DD, Weissman BE, Trent JM, Gilks CB, Huntsman DG. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type. J Pathol 2016;238:389-400. [PMID: 26356327 DOI: 10.1002/path.4633] [Cited by in Crossref: 130] [Cited by in F6Publishing: 136] [Article Influence: 18.6] [Reference Citation Analysis]
98 Dal Cin P. Tumors of the urinary tract. Cancer Cytogenetics 2015. [DOI: 10.1002/9781118795569.ch15] [Reference Citation Analysis]
99 Hagemann IS, Pfeifer JD, Huettner PC. The uterine corpus. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.039] [Reference Citation Analysis]
100 Jamshidi F, Nielsen TO, Huntsman DG. Cancer genomics: why rare is valuable. J Mol Med (Berl). 2015;93:369-381. [PMID: 25676695 DOI: 10.1007/s00109-015-1260-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
101 Hui P, Buza N. Uterine Mesenchymal Tumors. Atlas of Intraoperative Frozen Section Diagnosis in Gynecologic Pathology 2015. [DOI: 10.1007/978-3-319-21807-6_5] [Reference Citation Analysis]
102 Mahadevan P. Pathology of Uterine Sarcomas. Uterine Cancer 2015. [DOI: 10.1007/978-81-322-1892-0_11] [Reference Citation Analysis]
103 Soslow RA, Oliva E. Uterine Cancer: Pathology. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_7] [Reference Citation Analysis]
104 Gilks CB. Pathology of Gynecologic Cancers. Pelvic Cancer Surgery 2015. [DOI: 10.1007/978-1-4471-4258-4_25] [Reference Citation Analysis]
105 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2015. [DOI: 10.1007/978-1-4939-0727-4_27] [Reference Citation Analysis]
106 Palacios J, Dal Cin P. Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_6] [Reference Citation Analysis]
107 Spindle-cell and myxoid lesions. Diagnosis of Neoplasia in Endometrial Biopsies 2014. [DOI: 10.1017/cbo9781139628976.006] [Reference Citation Analysis]
108 Round-cell lesions. Diagnosis of Neoplasia in Endometrial Biopsies 2014. [DOI: 10.1017/cbo9781139628976.007] [Reference Citation Analysis]
109 Epithelioid-cell lesions. Diagnosis of Neoplasia in Endometrial Biopsies 2014. [DOI: 10.1017/cbo9781139628976.008] [Reference Citation Analysis]
110 van de Rijn M, Guo X, Sweeney RT, Beck AH, West RB. Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities. Histopathology 2014;64:163-70. [PMID: 24107169 DOI: 10.1111/his.12290] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
111 Feng W, Malpica A, Skaland I, Gudlaugsson E, Robboy SJ, Dalen I, Hua K, Zhou X, Baak JP. Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade? PLoS One 2013;8:e75899. [PMID: 24146786 DOI: 10.1371/journal.pone.0075899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
112 Binesh F, Zahir ST, Akhavan A, Bovanlu TR. Endometrial stromal sarcoma of the uterus presenting as pulmonary metastasis. BMJ Case Rep 2013;2013:bcr2013008565. [PMID: 23907964 DOI: 10.1136/bcr-2013-008565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
113 Sardinha R, Hernández T, Fraile S, Tresserra F, Vidal A, Gómez MC, Astudillo A, Hernández N, Saenz de Santamaría J, Ordi J, Gonçalves L, Ramos R, Balañá C, de Álava E. Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors. Clin Sarcoma Res 2013;3:3. [PMID: 23497641 DOI: 10.1186/2045-3329-3-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
114 Fisher C. Other Lesions. Atlas of Soft Tissue Tumor Pathology 2013. [DOI: 10.1007/978-1-4614-7025-0_16] [Reference Citation Analysis]
115 Brennan MF, Antonescu CR, Maki RG. Other Uterine Sarcomas. Management of Soft Tissue Sarcoma 2013. [DOI: 10.1007/978-1-4614-5004-7_21] [Reference Citation Analysis]
116 Lazar AJ. Applications of Molecular Testing to Differential Diagnosis. Practical Soft Tissue Pathology: A Diagnostic Approach 2013. [DOI: 10.1016/b978-1-4160-5455-9.00018-1] [Reference Citation Analysis]
117 Lee CH, Ali RH, Rouzbahman M, Marino-Enriquez A, Zhu M, Guo X, Brunner AL, Chiang S, Leung S, Nelnyk N, Huntsman DG, Blake Gilks C, Nielsen TO, Dal Cin P, van de Rijn M, Oliva E, Fletcher JA, Nucci MR. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol 2012;36:1562-70. [PMID: 22982899 DOI: 10.1097/PAS.0b013e31825fa931] [Cited by in Crossref: 148] [Cited by in F6Publishing: 153] [Article Influence: 14.8] [Reference Citation Analysis]
118 Davidson B, Abeler VM, Hellesylt E, Holth A, Shih IeM, Skeie-Jensen T, Chen L, Yang Y, Wang TL. Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma. Gynecol Oncol 2013;128:349-55. [PMID: 23178314 DOI: 10.1016/j.ygyno.2012.11.021] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
119 Devouassoux-shisheboran M, Croce S. Nouvelles perspectives et biomarqueurs dans le diagnostic et la prise en charge des tumeurs gynécologiques. Oncologie 2012;14:512-519. [DOI: 10.1007/s10269-012-2204-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]